阿巴洛帕拉提德和帕克利塔塞尔联合治疗 改善骨体积和瘤负担 骨转移性乳腺癌

Jade S Miller1,2,3,4, Jeremy F Kane1,3,5, Patricia A Ward1,2

  • 1Division of Hematology and Oncology, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA.

PubMed
概括

与阿巴洛帕拉提德和帕克利塔塞尔的联合治疗显示出减轻骨瘤负担和增加骨体积的前景. 单独的阿巴洛帕拉提德在这种癌症模型中没有影响瘤大小或骨密度.

相关概念视频

Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.8K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.0K